Freire Maria C 4
4 · EXELIXIS, INC. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
EXELIXIS, INC.EXEL
Freire Maria C
Director
Transactions
- Exercise/Conversion
Common Stock
2025-02-14$20.50/sh+15,874$325,417→ 106,881 total - Exercise/Conversion
Common Stock
2025-02-14$22.10/sh+28,240$624,104→ 135,121 total - Sale
Common Stock
2025-02-14$34.94/sh−44,114$1,541,343→ 91,007 total - Exercise/Conversion
Option (right to buy)
2025-02-14−15,874→ 0 totalExercise: $20.50From: 2018-05-24Exp: 2025-05-23→ Common Stock (15,874 underlying) - Exercise/Conversion
Option (right to buy)
2025-02-14−28,240→ 0 totalExercise: $22.10From: 2018-04-05Exp: 2025-04-04→ Common Stock (28,240 underlying)
Footnotes (4)
- [F1]Includes 18,838 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
- [F2]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $34.92 to $35.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- [F3]The option, representing the right to purchase a total of 15,874 shares of Common Stock, became fully exercisable on May 24, 2018.
- [F4]The option, representing the right to purchase a total of 28,240 shares of Common Stock, became fully exercisable on April 5, 2018.